Literature DB >> 8610103

Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease.

A Yoritaka1, N Hattori, K Uchida, M Tanaka, E R Stadtman, Y Mizuno.   

Abstract

There is growing evidence that oxidative stress and mitochondrial respiratory failure with attendant decrease in energy output are implicated in nigral neuronal death in Parkinson disease (PD). It is not known, however, which cellular elements (neurons or glial cells) are major targets of oxygen-mediated damage. 4-Hydroxy-2-nonenal (HNE) was shown earlier to react with proteins to form stable adducts that can be used as markers of oxidative stress-induced cellular damage. We report here results of immunochemical studies using polyclonal antibodies directed against HNE-protein conjugates to label the site of oxidative damage in control subjects (ages 18-99 years) and seven patients that died of PD (ages 57-78 years). All the nigral melanized neurons in one of the midbrain sections were counted and classified into three groups according to the intensity of immunostaining for HNE-modified proteins--i.e., no staining, weak staining, and intensely positive staining. On average, 58% of nigral neurons were positively stained for HNE-modified proteins in PD; in contrast only 9% of nigral neurons were positive in the control subjects; the difference was statistically significant (Mann-Whitney U test; P < 0.01). In contrast to the substantia nigra, the oculomotor neurons in the same midbrain sections showed no or only weak staining for HNE-modified proteins in both PD and control subjects; young control subjects did not show any immunostaining; however, aged control subjects showed weak staining in the oculomotor nucleus, suggesting age-related accumulation of HNE-modified proteins in the neuron. Our results indicate the presence of oxidative stress within nigral neurons in PD, and this oxidative stress may contribute to nigral cell death.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8610103      PMCID: PMC39693          DOI: 10.1073/pnas.93.7.2696

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  Neuromelanin-containing neurons of the substantia nigra accumulate iron and aluminum in Parkinson's disease: a LAMMA study.

Authors:  P F Good; C W Olanow; D P Perl
Journal:  Brain Res       Date:  1992-10-16       Impact factor: 3.252

2.  Immunohistochemical studies on complexes I, II, III, and IV of mitochondria in Parkinson's disease.

Authors:  N Hattori; M Tanaka; T Ozawa; Y Mizuno
Journal:  Ann Neurol       Date:  1991-10       Impact factor: 10.422

3.  Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease.

Authors:  C D Smith; J M Carney; P E Starke-Reed; C N Oliver; E R Stadtman; R A Floyd; W R Markesbery
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

4.  Protein oxidative damage is associated with life expectancy of houseflies.

Authors:  R S Sohal; S Agarwal; A Dubey; W C Orr
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-01       Impact factor: 11.205

5.  Formation of 4-hydroxy-2-nonenal-modified proteins in the renal proximal tubules of rats treated with a renal carcinogen, ferric nitrilotriacetate.

Authors:  S Toyokuni; K Uchida; K Okamoto; Y Hattori-Nakakuki; H Hiai; E R Stadtman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-29       Impact factor: 11.205

6.  Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis.

Authors:  D R Rosen; T Siddique; D Patterson; D A Figlewicz; P Sapp; A Hentati; D Donaldson; J Goto; J P O'Regan; H X Deng
Journal:  Nature       Date:  1993-03-04       Impact factor: 49.962

Review 7.  Why are nigral catecholaminergic neurons more vulnerable than other cells in Parkinson's disease?

Authors:  E C Hirsch
Journal:  Ann Neurol       Date:  1992       Impact factor: 10.422

Review 8.  Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease. The Royal Kings and Queens Parkinson's Disease Research Group.

Authors:  P Jenner; D T Dexter; J Sian; A H Schapira; C D Marsden
Journal:  Ann Neurol       Date:  1992       Impact factor: 10.422

9.  Toxic and protective effects of L-dopa on mesencephalic cell cultures.

Authors:  C Mytilineou; S K Han; G Cohen
Journal:  J Neurochem       Date:  1993-10       Impact factor: 5.372

10.  Iron-melanin complex in substantia nigra of parkinsonian brains: an x-ray microanalysis.

Authors:  K Jellinger; E Kienzl; G Rumpelmair; P Riederer; H Stachelberger; D Ben-Shachar; M B Youdim
Journal:  J Neurochem       Date:  1992-09       Impact factor: 5.372

View more
  258 in total

Review 1.  The role of iron in neurodegeneration: prospects for pharmacotherapy of Parkinson's disease.

Authors:  K A Jellinger
Journal:  Drugs Aging       Date:  1999-02       Impact factor: 3.923

2.  Naturally occurring genetic variability in expression of Gsta4 is associated with differential survival of axotomized rat motoneurons.

Authors:  Mikael Ström; Faiez Al Nimer; Rickard Lindblom; Jens Randel Nyengaard; Fredrik Piehl
Journal:  Neuromolecular Med       Date:  2011-12-08       Impact factor: 3.843

Review 3.  Modulation of oxidative stress and mitochondrial function by the ketogenic diet.

Authors:  Julie Milder; Manisha Patel
Journal:  Epilepsy Res       Date:  2011-11-09       Impact factor: 3.045

4.  Experimental strategy to identify genes susceptible to oxidative stress in nigral dopaminergic neurons.

Authors:  Myung S Yoo; Hibiki Kawamata; Dae J Kim; Hong S Chun; Jin H Son
Journal:  Neurochem Res       Date:  2004-06       Impact factor: 3.996

5.  Differentiation of SH-SY5Y cells to a neuronal phenotype changes cellular bioenergetics and the response to oxidative stress.

Authors:  Lonnie Schneider; Samantha Giordano; Blake R Zelickson; Michelle S Johnson; Gloria A Benavides; Xiaosen Ouyang; Naomi Fineberg; Victor M Darley-Usmar; Jianhua Zhang
Journal:  Free Radic Biol Med       Date:  2011-09-01       Impact factor: 7.376

6.  The reactivity of human serum albumin toward trans-4-hydroxy-2-nonenal.

Authors:  Qingyuan Liu; David C Simpson; Scott Gronert
Journal:  J Mass Spectrom       Date:  2012-04       Impact factor: 1.982

7.  HSF1-mediated BAG3 expression attenuates apoptosis in 4-hydroxynonenal-treated colon cancer cells via stabilization of anti-apoptotic Bcl-2 proteins.

Authors:  Aaron T Jacobs; Lawrence J Marnett
Journal:  J Biol Chem       Date:  2009-01-29       Impact factor: 5.157

8.  Autoantibodies to the C-terminal subunit of RLIP76 induce oxidative stress and endothelial cell apoptosis in immune-mediated vascular diseases and atherosclerosis.

Authors:  Paola Margutti; Paola Matarrese; Fabrizio Conti; Tania Colasanti; Federica Delunardo; Antonella Capozzi; Tina Garofalo; Elisabetta Profumo; Rachele Riganò; Alessandra Siracusano; Cristiano Alessandri; Bruno Salvati; Guido Valesini; Walter Malorni; Maurizio Sorice; Elena Ortona
Journal:  Blood       Date:  2007-11-09       Impact factor: 22.113

Review 9.  Oxidative damage to macromolecules in human Parkinson disease and the rotenone model.

Authors:  Laurie H Sanders; J Timothy Greenamyre
Journal:  Free Radic Biol Med       Date:  2013-01-15       Impact factor: 7.376

Review 10.  Oxidative stress in Parkinson's disease: a mechanism of pathogenic and therapeutic significance.

Authors:  Chun Zhou; Yong Huang; Serge Przedborski
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.